Acute viral infections typically generate functional effector CD8 + T cells (T CD8 ) that aid in pathogen clearance. However, during acute viral lower respiratory infection, lung T CD8 are functionally impaired and do not optimally control viral replication. T cells also become unresponsive to Ag during chronic infections and cancer via signaling by inhibitory receptors such as programmed cell death-1 (PD-1). PD-1 also contributes to T CD8 impairment during viral lower respiratory infection, but how it regulates T CD8 impairment and the connection between this state and T cell exhaustion during chronic infections are unknown. In this study, we show that PD-1 operates in a cell-intrinsic manner to impair lung T CD8 . In light of this, we compared global gene expression profiles of impaired epitope-specific lung T CD8 to functional spleen T CD8 in the same human metapneumovirus-infected mice. These two populations differentially regulate hundreds of genes, including the upregulation of numerous inhibitory receptors by lung T CD8 . We then compared the gene expression of T CD8 during human metapneumovirus infection to those in acute or chronic lymphocytic choriomeningitis virus infection. We find that the immunophenotype of lung T CD8 more closely resembles T cell exhaustion late into chronic infection than do functional effector T cells arising early in acute infection. Finally, we demonstrate that trafficking to the infected lung alone is insufficient for T CD8 impairment or inhibitory receptor upregulation, but that viral Ag-induced TCR signaling is also required.
C D8
+ T cells (T CD8 ) possess critical functions that protect against intracellular pathogens and cancer, including cytotoxicity, cytokine production, and long-lived memory potential (1, 2). During acute infection, naive T CD8 encounter Ag, acquire effector functions, and proliferate to clear the infection, after which 90-95% die whereas the remaining few become memory cells (2). Memory T CD8 can rapidly reactivate their effector functions and proliferate upon pathogen re-encounter, contributing to protective immunity (3). During chronic infection, a different sequence of events occurs: pathogen-specific T CD8 initially acquire effector functions, but they gradually become exhausted and fail to eliminate the infection (4). Proliferation and IL-2 production are lost early, followed by TNF, with IFN-g production failing weeks into exhaustion (5). Prolonged TCR stimulation by persistent viral or tumor Ags is thought to transcriptionally reprogram exhausted T CD8 , resulting in these functional changes (6).
The paradigm that acute infection generates functional effector T cells followed by memory development, while chronic infection causes T cell exhaustion, is not generalizable to all infections. During acute viral lower respiratory infection (LRI) in mice, pulmonary T CD8 become functionally impaired, rapidly losing cytotoxicity and cytokine production (7-11). In contrast to exhaustion, lung T CD8 impairment during LRI occurs rapidly, with IFN-g production waning as early as day 7 (7). Additionally, only T CD8 in the respiratory tract become impaired; T CD8 in lymphoid organs maintain their effector functions, suggesting that the infected lung environment is critical for the development of impairment (12). LRI are typically cleared within 7-12 d even in the face of T CD8 impairment, but the generation of protective immunity may be compromised by the rapid impairment of the primary and secondary anti-viral T CD8 effector responses (13) . Failure to generate a quality memory T CD8 response may help explain the ability of respiratory viruses and other pathogens to repeatedly reinfect individuals despite minimal antigenic drift (14) (15) (16) . A better understanding of the phenotype, functions, and mechanisms controlling lung T CD8 activity during LRI is needed to design new and effective therapeutics and vaccines.
We previously uncovered a role for the inhibitory receptor programmed cell death-1 (PD-1) in mediating lung T CD8 impairment during human metapneumovirus (HMPV) and influenza virus infection (12). Blocking PD-1 during LRI resulted in increased T CD8 degranulation, IFN-g production, and ability to clear the infection. A recent study showed that during respiratory syncytial virus (RSV) infection, PD ligand-1 (PD-L1) expression by lung dendritic cells (DCs) primarily mediated lung T CD8 impairment (17) . PD-1 has been proposed to play a role during other acute infections, including rabies (18) , histoplasmosis (19) , and bacterial sepsis (20, 21) . However, PD-1 expression by APCs (e.g., microglia, macrophages, DCs) was found to be primarily important in mediating early susceptibility to these pathogens. Recently, it was shown that PD-1 expression on lung T CD8 correlated with disease severity caused by different strains of influenza virus and PD-1 blockade improved survival, but this was not associated with restored T CD8 functionality (22) . Therefore, the intrinsic ability of PD-1 to regulate adaptive immune responses during acute LRI remains unclear.
PD-1 blockade restores function to exhausted T CD8 during HIV infection in humans (23) and chronic lymphocytic choriomeningitis virus (LCMV) clone 13 infection of mice (24). PD-1 is not the sole mediator of exhaustion, however, as additionally inhibitory receptors, including TIM-3 (25), LAG-3 (26), 2B4 (27), and others (28), also contribute. The PD-1-mediated functional impairment in both acute viral LRI and chronic systemic infection suggests that additional similarities may exist during these seemingly disparate infections. However, whether additional inhibitory receptors are expressed, what drives their expression, and whether they play a role in lung T CD8 impairment during acute viral LRI are unknown.
We addressed these issues by first determining that PD-1 regulates lung T CD8 in a cell-intrinsic manner during HMPV infection. This then allowed us to more directly study the phenotype of impaired lung T CD8 . We compared the global gene expression profiles of impaired virus-specific lung T CD8 to unimpaired spleen T CD8 in the same HMPV-infected mice. Gene expression analysis has uncovered numerous pathways regulating effector and memory T CD8 development during acute infection (29) and exhaustion during chronic infection (4, 30). Given the functional differences that exist between effector T CD8 present during most acute infections, exhausted T CD8 during chronic infections, and impaired lung T CD8 during LRI, we hypothesized that each population would possess a unique gene expression profile that may provide insights into the mechanisms governing each functional state. Surprisingly, we found that the lung T CD8 gene expression signature was similar to T CD8 early in the exhaustion process; however, when focusing solely on genes with known immune functions, impaired lung T CD8 were most similar to fully exhausted cells. We confirmed that impaired lung T CD8 coexpress these inhibitory receptors to a greater degree than do spleen T CD8 . Finally, we show that T CD8 inhibitory receptor expression is driven by Ag-dependent TCR signaling, and without TCR stimulation, T CD8 remain functional with very low inhibitory receptor expression. Our results indicate that acute viral LRI induces an exhaustion-like state in lung T CD8 characterized by rapid functional impairment and Ag-dependent upregulation of numerous inhibitory receptors.
Materials and Methods
Mice and viral infection C57BL/6 (B6) and congenic Thy1.1 + mice were purchased from The Jackson Laboratory. B6-Kb 0 Db 0 ;B7.2 transgenic mice were obtained with permission from Drs. Alexander Sette (La Jolla Institute for Allergy and Immunology, La Jolla, CA) and François Lemonnier (Institut Pasteur, Paris, France). PD-1 2 /2 mice were obtained with permission from Dr. Tasuku Honjo (Kyoto University, Kyoto, Japan). All animals were bred and maintained in specific pathogen-free conditions in accordance with the Vanderbilt Institutional Animal Care and Use Committee. Six-to twelveweek-old age-and gender-matched animals were used in all experiments. Mixed bone marrow chimeric mice were generated by irradiating Thy1.1 + recipients with two doses of 5 Gy, 4 h apart, followed by reconstitution with 1 3 10 6 wild-type (WT; Thy1.1 + ) and 1 3 10 6 PD-1 2/2 (Thy1.2 + ) bonemarrow cells 24 h later. Mice were rested for 8 wk and then bled to check reconstitution before use in experiments. HMPV (pathogenic clinical strain TN/94-49, genotype A2) was grown and titered in LLC-MK2 cells as previously described (31). For all experiments, mice were anesthetized with ketamine-xylazine and infected intranasally (i.n.) with 1 3 10 6 PFU HMPV.
Flow cytometry staining
Tetramers were generated for the following viral epitopes as previously described (12, 32): HLA-B*0702/M 195-203 (M195) (APYAGLIMI), H2-D b /F 528-536 (F528) (SGVTNNGFI), and H2-K b /N 11-18 (N11) (LSY-KHAIL). Lymphocytes were isolated from spleens and lungs of infected animals and stained as previously described (12). Cells were stained with PE-or allophycocyanin-labeled tetramers (0.1-1 mg/ml), anti-CD8a (clone 53-6.7, BD Biosciences), and anti-CD19 (clone 1D3, iCyt). In some experiments, cells were also stained for the inhibitory receptors PD-1 (clone RMP1-30), TIM-3 (clone RMT3-23), LAG-3 (clone C9B7W), and 2B4 [clone m2B4 (B6)458.1] or with appropriate isotype controls (all from BioLegend). For mixed bone marrow chimera experiments, cells were stained for Thy1.1 (clone OX-7, BD Biosciences) and Thy1.2 (clone 53-2.1, BD Biosciences). Surface/tetramer staining was performed for 1 h at room temperature in PBS containing 1% FBS and 50 nM dasatinib. Intracellular cytokine staining (ICS) was performed in parallel with tetramer staining as previously described (12). Flow cytometric data were collected using an LSR II or LSRFortessa (BD Biosciences) and analyzed with FlowJo software (Tree Star). Boolean gating in FlowJo was used to assess inhibitory receptor coexpression, and patterns were visualized using the SPICE program (National Institute of Allergy and Infectious Diseases).
Generation of bone marrow-derived DCs and immunizations
Bone marrow-derived DCs were generated as previously described (12) . To obtain secondary M195-specific T CD8 , mice were primed i.n. with 2 3 10 6 M195-loaded, LPS-matured DCs and then challenged with HMPV 3 wk later. For generation of lung-infiltrating vaccinia virus A34R 82-90 (A34R)-specific T CD8 , mice were immunized i.n. with A34R DCs and then challenged 7 d later with HMPV and were treated daily i.n. during the infection with either 50 mg A34R peptide or an irrelevant HLA-B*0702-restricted peptide. To study splenic T CD8 response to systemically administered Ag, mice were immunized s.c. with A34R-specific DCs, challenged 7 d later with HMPV, and injected daily s.c. and i.p. during the infection with either 50 mg (via each route) A34R peptide or mock peptide.
Cell sorting
To obtain sufficient quantities of primary epitope-specific T CD8 , on day 7 after HMPV infection the spleens and lungs from three mice were pooled together after processing. Samples were stained, sorted, and RNA purified on separate days in independent experiments. Cells were processed in icecold R10 media containing 10 nM dasatinib to prevent activation and TCR signaling. Lung cells were processed as before. Splenocytes were depleted of B cells by incubation on goat anti-mouse IgG-and IgM-coated (100 mg/ml) (SouthernBiotech) T-75 flasks at 10 6 cells/ml for 1 h at 37˚C and then processed as before. Both lung and spleen cells were stained for viability, CD19, CD8, and M195 tetramers (both PE and allophycocyanin conjugated). Splenocytes were also stained for CD44 (clone IM-7; BD Biosciences) and CD62L (MEL-14; BD Biosciences) to obtain control naive cells. Dual tetramer + T CD8 were sorted using a BD FACSAria III. Samples were maintained at 4˚C for the entirety of the sort and purity was 97-99% for all populations. integrity and then hybridized to mouse gene 1.1 ST microarrays (Affymetrix) and scanned on the GeneTitan instrument (Affymetrix).
Microarray data analysis
HMPV T CD8 data analysis. Microarray data were processed using the oligonucleotide package implementation of rma in R software (33). For microarray analysis, four groups (naive, spleen, lung, and secondary lung) were compared using the limma package (34). Significantly changed probes were identified by ANOVA. The p values were adjusted for multiple comparisons using the false discovery rate (FDR) method (35). The thresholds for significance were set to control the expected FDR at values ,10% and the fold-change at 2. HMPV data versus LCMV data. GSE41867 data (26) were downloaded from the National Center for Biotechnology Information Gene Expression Omnibus database. The microarray data files from the present study and GSE41867 were processed separately using the oligonucleotide package implementation of rma in R software. The batch effect of two data sets was corrected using ComBat package (36). In one analysis, five groups (spleen and lung are from the HMPV data set and the additional three groups are from GSE41867 data) were selected to a subset (top 50% based on the coefficient of variation) of the original data and 10 pairwise comparisons were done using the limma package in BioConductor (34). The differentially expressed probes/genes were refined to the gene list based on two criteria: adjusted p value ,0.1 and foldchange .2. Analysis of similarity was also performed as previously described (37). In a separate analysis, all groups were compared using ANOVA with the same cutoffs for significance and a heat map was generated.
Ingenuity Pathway Analysis
Ingenuity Pathway Analysis (http://www.ingenuity.com) was used to compare different biological processes in spleen versus lung T CD8 and to identify all immune genes present in each data set.
Accession numbers
The microarray data have been submitted to the Gene Expression Omnibus database (http://www.ncbi.nlm.nih.gov/gds) under the accession number GSE53349.
Statistical analysis
Comparisons between tetramer staining and ICS within the same animals were performed using a paired t test or Wilcoxon signed rank test. Comparisons between two independent groups were performed using an unpaired Student t test or Wilcoxon rank sum test. Multiple group comparisons were performed using one-way ANOVA with a Bonferroni posttest for comparison of individual groups. A p value ,0.05 was considered statistically significant by convention. All p values should be for two-sided tests and unadjusted for multiple comparisons unless otherwise noted. Error bars on each graph represented the SEM unless otherwise noted. All analyses were conducted using R software version 2.16.
Study approval
All animals were maintained in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals and were handled according to protocols approved by the Vanderbilt University subcommittee on animal care (Institutional Animal Care and Use Committee).
Results
Lung T CD8 impairment is cell-intrinsically regulated by PD-1
We have previously shown that blockade or genetic ablation of PD-1 reverses functional impairment (12). However, it was unclear whether PD-1 caused impairment via direct signaling on the T CD8 surface or whether its effects were indirectly mediated by other immune cells. To answer this question, we generated WT:PD-1 (Fig. 1A) . This was true in both the preinfection blood and the postinfection lung compartments (Fig. 1A) , indicating a stable ratio of WT:PD-1 2/2 T cells following HMPV infection. + lymphocytes is shown. In the graph, each symbol represents an individual mouse and the horizontal bar indicates the mean. Ratios of WT:PD-1 2/2 T CD8 in preinfection blood (n) and postinfection lungs (s) sum to 100%. (B) Mixed bone marrow chimeric mice were infected with HMPV and the lung F528-and N11-specific T CD8 responses were quantified via tetramer staining (black bars), CD107a mobilization (gray bars), and intracellular IFN-g production (white bars) at day 7 p.i. Data are combined from three independent experiments with four to five mice per experiment. We quantified the total F528 and N11 epitope-specific T CD8 response on day 7 postinfection (p.i.) via tetramer staining, and in parallel their effector functions via brief peptide restimulation followed by intracellular cytokine staining. We have previously shown that direct comparison of these assays allows for the accurate quantification of the functionality of epitope-specific lung T CD8 in a manner that is not influenced by variations in lung APCs or in vitro stimulation conditions (12, 13, 38 Gene expression analysis of impaired lung T CD8 and unimpaired spleen T CD8
Given the cell-intrinsic nature of PD-1-mediated lung T CD8 impairment, we reasoned that a more thorough examination of anti-viral T CD8 might reveal other mechanisms regulating their function in the respiratory tract. We previously showed that HMPV-specific T CD8 in different environments within the same infected mouse have different levels of functionality (12). We found that HMPV-specific lung T CD8 rapidly lose the ability to produce IFN-g ( Fig. 2A) or degranulate (not shown), although these effector functions are maintained in the spleen over time. HMPV is cleared from the lungs by day 10 (12), yet T CD8 exhibited progressive functional decline long after infection. Secondary lung T CD8 are also highly impaired in their ability to degranulate or make cytokines following challenge of previously infected mice or mice immunized with HMPV-specific class I-restricted epitopes (12, 13). We hypothesized that the infected lung environment influences T CD8 functionality at a transcriptional level to balance the need for viral control with prevention of immune-mediated pathology. To test this, we compared global gene expression differences between virus-specific, impaired lung T CD8 and functional spleen T CD8 from the same HMPV-infected mice. We infected B6-Kb (12) . At day 7 p.i., the time at which lung T CD8 impairment begins ( Fig. 2A) , we sorted spleen and lung M195-specific T CD8 as well as secondary lung M195-specific T CD8 from mice primed with M195-loaded DCs then challenged with HMPV. M195-specific T CD8 were sorted to high purity (Fig. 2B ) and gene expression analysis was performed. Two samples were deemed outliers based on principal component analysis and excluded from further study (Supplemental Fig. 1) .
We quantified the gene expression differences of these populations and compared them to naive T CD8 to make direct comparisons between the three groups. Approximately 900 genes were up-or downregulated by all three populations of M195-specific T CD8 compared with naive T CD8 (Fig. 2C) , which reflect many genes associated with T cell activation and differentiation (Table I) . More than 1300 genes were differentially expressed by both primary and secondary lung T CD8 (Supplemental Table I ). Despite large numbers of overlapping genes between these groups, each population contained numerous genes uniquely identifying them: 173 for spleen, 319 for primary lung, and 652 for secondary lung T CD8 (Fig. 2C) . A total of 370 genes differed between the impaired lung and unimpaired spleen T CD8 from the same infected mice, indicating that lung anti-viral T CD8 exhibit a unique gene expression profile while combating infection.
Activated spleen and lung T CD8 up-and downregulated numerous genes compared with naive T CD8 (Fig. 3A , Table I) in concordance with previous studies (29, 40). Some of these genes were shared by both spleen and lung T CD8 , but lung T CD8 also upregulated numerous unique genes. Gene clustering demonstrated that primary and secondary lung T CD8 were most closely related, with numerous additional genes only expressed during challenge infection (Fig. 3A) . To broadly compare which biological processes were altered in lung compared with spleen antiviral T CD8 , we performed gene ontology analysis (Fig. 3B) . Numerous pathways were substantially altered in primary lung T CD8 ; "cellular function and maintenance" was the most significantly changed. Other pathways with known immune functions were altered in lung T CD8 , including "hematological system development and function," "immune cell trafficking," "inflammatory response," and "cell death and survival." Genes were then sorted by functional classification and biological process so that just the FIGURE 2. Isolation of epitope-specific lung and spleen T CD8 and comparison of gene expression. (A) Time course of HMPV M195-specific T CD8 functionality (IFN-g production) in the lung and the spleen. (B) Pre-and postsort analysis of lung M195-specific T CD8 at day 7 p.i. (C) Total number of genes differentially expressed for the indicated M195-specific T CD8 populations compared with naive T CD8 . Naive spleen T CD8 , spleen M195-specific T CD8 , lung M195-specific T CD8 , and 2˚lung M195-specific T CD8 are shown. Genes were considered significantly different when the fold-change was .2 and the FDR was ,10%.
subset of immune genes could be compared. This analysis revealed that spleen T CD8 very closely resemble naive T CD8 , indicating a state of immune immaturity (Fig. 3C) . Conversely, lung T CD8 upregulated the expression of dozens of additional immune genes, suggesting that lung-homing virus-specific T CD8 adopt a significantly more differentiated state to combat viral infection. These results indicate that lung T CD8 are immunologically more mature than spleen T CD8 and display a distinct gene expression profile.
Genes encoding several inhibitory receptors and pathways are upregulated in impaired lung T CD8
Several genes encoding inhibitory receptors, which can contribute to T cell exhaustion during chronic infection, were highly expressed by impaired lung T CD8 (Fig. 3C , Table I ). These genes encode the receptors TIM-3 (Havcr2), LAG-3 (Cd233), and 2B4 (Cd244). Pdcd1, the gene that encodes PD-1, was not differentially expressed between spleen and lung T CD8 , which may reflect either recent activation of spleen T CD8 or migration from the infected lung where they had encountered Ag. FGL2, an inhibitory molecule expressed by regulatory T cells that has been shown to inhibit adaptive immunity (41) and also promote T cell exhaustion during chronic LCMV infection (42), was also highly upregulated by lung T CD8 . Interestingly, other known inhibitory receptors, such as CTLA-4, CD160, and BTLA, were not different between any of the groups. The activating receptors OX40 and 4-1BB were upregulated in the lung compared with the spleen, but not as dramatically. Of note, many genes encoding adhesion molecules, cytokines, chemokines, and various others were also significantly different (Supplemental Table I, Table I ). In summary, impaired lung T CD8 displayed coordinated upregulation of several genes associated with T cell exhaustion.
Impaired lung T CD8 adopt an exhaustion-like state during viral LRI
Functional impairment in association with upregulation of inhibitory receptors has also been observed in exhausted T CD8 during chronic infection. However, important differences exist, including the speed with which lung T CD8 impairment versus exhaustion develops (days versus weeks). We sought to determine whether CD244  CCL1  CD14  IRF7   FGL2  CCL4  CYBB  IRF8   HAVCR2  CCL7  CYSLTR2  JUN   LAG3  CCR7  HP  MYB   PDCD1  CCR8  ISG15  MYC   TNFRSF4  CCRL2  ISG20  PRDM1   TNFRSF9  CXCL3  MGST1  RBPJ   TREML2  CXCL9  RSAD2 impaired lung T CD8 resemble exhausted T cells at a global transcriptional level by comparing the gene expression differences of lung T CD8 during acute viral LRI to functional effector T CD8 during acute LCMV Armstrong (Arm) infection as well as exhausted T CD8 during chronic LCMV clone 13 (Cl-13) infection (30). We found that anti-HMPV spleen and lung T CD8 gene expression differed by 257 genes (R = 0.70) in this analysis, whereas anti-LCMV T CD8 at day 8 during Arm infection and day 30 during Cl-13 infection differed by 337 genes (R = 0.43) (Fig. 4A) . Interestingly, anti-HMPV lung T CD8 differed by only 34 genes compared with anti-LCMV T CD8 at day 8 during Cl-13 infection (R = 0.48), which increased to 161 genes at day 30 p.i. (R = 0.63).
Compared to effector T CD8 at day 8 after Arm infection, anti-HMPV lung T CD8 differed by 83 genes (R = 0.31) whereas anti-HMPV spleen T CD8 differed by only 5 genes (R = 0.06). These results suggest that impaired lung T CD8 gene expression most closely resembles exhausted T CD8 early during chronic infection.
In a separate analysis, we compared each T CD8 population based on patterns of gene expression. This experiment also revealed that lung T CD8 most closely resemble T CD8 early during Cl-13 infec- Immunity-related genes were identified using Ingenuity Pathway Analysis and are displayed in a heat map comparing all four groups. Genes were considered significantly different when the fold-change was .2 and the FDR was ,10%. tion (day 8 p.i.), followed by functional effectors during Arm infection (Fig. 4B) . However, each LCMV group differentially regulated numerous genes compared with lung T CD8 . The number of genes differentially expressed in these groups was similar to what we found when comparing the groups head-to-head, which showed that lung T CD8 exhibited gene regulation patterns with features of both early CL-13 and late Cl-13 (Fig. 4C) . Out of the total gene set for this analysis, we next compared only the genes with known immune functions. We found that anti-HMPV lung T CD8 most closely resemble exhausted anti-LCMV T CD8 at day 30 after Cl-13 infection (Fig. 4D) . In this analysis, anti-HMPV spleen T CD8 were more closely related to D8 Cl-13 and Arm T CD8 . Of note, when comparing all genes or just immune genes, anti-HMPV lung T CD8 also uniquely express numerous genes that are not shared by any of the other populations (Fig. 4B, 4C , Supplemental Table II ). These results indicate that lung T CD8 global gene expression closely resembles T CD8 that are destined to become exhausted (day 8 Cl-13), whereas the lung T CD8 immunophenotype most closely resembles fully exhausted T CD8 (day 30 Cl-13). Therefore, the infected lung environment rapidly induces a transcriptional state associated with exhaustion in lung T CD8.
To confirm that increased inhibitory receptor gene expression during acute LRI corresponds to increased cell surface expression, we performed flow cytometric analysis of lung and spleen M195-specific T CD8 at day 7 after HMPV infection. Despite similar Pdcd1 mRNA levels (Table I) , surface PD-1 expression was greater on lung T CD8 at day 7 (Fig. 5A) . The same was true for TIM-3 and LAG-3. 2B4 expression was also higher in the lung. Additionally, we found considerable coexpression of these inhibitory receptors on lung T CD8, with most lung T CD8 expressing two or more inhibitory receptors by day 7 p.i.; in contrast, most splenic T CD8 expressed one or no inhibitory receptors (Fig. 5B) . Thus, impaired lung T CD8 are associated with the coexpression of multiple inhibitory receptors.
Viral Ag-mediated T CD8 functional impairment is lung specific
Ag-induced TCR signaling is associated with PD-1 upregulation during chronic infections (23, 24, 43, 44). To determine whether viral Ag is necessary for lung T CD8 impairment and inhibitory receptor upregulation, we took advantage of the fact that i.n. DC immunization elicits unimpaired, PD-1 low T CD8 directly in the lung (12). We immunized mice i.n. with LPS-maturated bone marrow-derived DCs loaded with the vaccinia virus-derived epitope A34R, challenged them with HMPV a week later, and delivered cognate A34R peptide i.n. to induce TCR signaling or a control (mock) HLA-B*0702-restricted peptide (Fig. 6A) . Of note, mice receiving mock peptide did not lose weight during the infection (HMPV does not cause clinical disease in mice), whereas those receiving A34R peptide lost nearly 25% of their body weight (Fig. 6B) . The endogenous M195 response was greatly diminished in A34R-treated mice and so was not included in the following analysis. Heterologous A34R-specific T CD8 in mice receiving mock peptide were minimally impaired, whhereas M195-specific T CD8 in the same infected lungs were impaired (Fig. 6C) . In contrast, A34R-specific T CD8 in mice receiving cognate peptide expanded in number but were severely impaired (Fig. 6C) .
Compared to M195-specific cells, fewer A34R-specific T CD8 in mock-treated mice expressed PD-1, TIM-3, LAG-3 (Fig. 7A ), or 2B4 (not shown). However, A34R-specific T CD8 expressed very high levels of inhibitory receptors in mice treated with cognate Ag A34R peptide (Fig. 7A) . Furthermore, in the mock peptide-treated mice, inhibitory receptor coexpression was low in A34R-specifc T CD8 (Fig. 7B) , with most cells expressing one or no receptors. A34R-specific T CD8 in A34R peptide-treated mice highly coexpressed all four of the inhibitory receptors we analyzed. Their expression eclipsed that of even the M195-specific T CD8 that also were exposed to the presence of cognate Ag due to HMPV infection. Therefore, the large degree of functional impairment observed in A34R peptide-treated mice (Fig. 6 ) was associated with a dramatic increase in inhibitory receptor coexpression. Thus, cognate Ag-induced TCR signaling in the context of pulmonary infection promotes lung T CD8 impairment and inhibitory receptor coexpression.
To show that this phenomenon is specific to the lung environment, we systemically immunized mice with A34R-specific DCs via the s.c. route and then injected them daily s.c. and i.p. with either A34R or mock peptide during HMPV infection (Fig. 8A) . In mice treated with either mock or A34R peptide, the A34R-specific spleen T CD8 were equally functional as measured by CD107a mobilization and IFN-g production (Fig. 8B ). Splenic T CD8 specific for the HMPV epitope M195 were unimpaired, as shown previously (12, 45). A34R-specific T CD8 in mice treated with mock peptide had low expression of PD-1, TIM-3, LAG-3, and 2B4 ( Fig. 8C and not shown) and most of these cells expressed one or no inhibitory receptors (Fig. 8D) . Splenic M195-specific T CD8 treated with mock peptide (but exposed to cognate Ag through HMPV infection) upregulated inhibitory receptor expression despite retaining functionality. However, A34R-specific T CD8 in mice treated with cognate A34R peptide increased expression of PD-1, TIM-3, LAG-3, and 2B4. As in the lung (Fig. 7A ), A34R-specific T CD8 in mice treated with Ag A34R peptide expressed higher levels of TIM-3 and LAG-3 than did M195-specific T CD8 . Moreover, these cells exhibited substantial coexpression of multiple inhibitory receptors, with 70% coexpressing two or more inhibitory receptors. These results confirm that Ag-induced TCR signaling mediates inhibitory receptor expression, but more conclusively demonstrate that the location of T CD8 in the lung is critical for the development of the exhaustionlike phenotype, because splenic T CD8 remain functional despite Ag stimulation and upregulation of inhibitory receptors.
Discussion
In this study, we sought to further elucidate mechanisms of T CD8 impairment during acute viral LRI and better define the dysfunctional effector state observed in pulmonary T CD8 . We first determined that lung T CD8 impairment was cell-intrinsically regulated by PD-1. Importantly, this excluded a role for other PD-1-expressing cell types in mediating T CD8 functional impairment. PD-1 signaling has been shown to affect multiple immune cells (e.g., macrophages and DCs) during other acute infections (20, 21) . A T CD8 -intrinsic role for PD-1 was suggested by in vitro studies showing that blocking PD-L1 on epithelial cells during RSV infection (46) or microglial cells during coronavirus infection (47) resulted in increased IFN-g production by memory T CD8 . Bone marrow chimeric experiments confirmed an intrinsic role for PD-1 in impairing T CD8 memory development and secondary responses after VACV infection (48). In the present study, we used bone marrow chimeric mice to show that PD-1 cellintrinsically regulates T CD8 functions during acute viral LRI. The contribution of T CD8 -intrinsic PD-1 signaling to viral clearance cannot be assessed using this model, so the possibility exists that PD-1 expression by other immune cells is responsible for the increased viral replication observed in PD-1-expressing mice (12).
Several studies have shown that HMPV and RSV infection of DCs impaired the ability of these DCs to prime an effective T cell response; however, none of these studies reported on inhibitory ligand expression by DCs (49-52). We found previously that PD-L1 and other inhibitory receptors are expressed at substantially different levels by different subsets of APCs in the lung, and this expression was partially modulated by type I IFN expression (38). Yao et al. (17) recently reported that during RSV infection, inflammatory DC-derived PD-L1 directly inhibits cytokine production by effector T cells in vitro and in vivo. Thus, inhibitory ligand expression by APCs may contribute to lung T CD8 impairment. However, several lines of evidence support persistence of the intrinsic T CD8 impaired phenotype induced by respiratory virus infection. First, in our initial study describing lung T CD8 impairment, we showed that HMPV-specific lung T CD8 were impaired at numerous time points after infection and after reinfection, whereas splenic T CD8 remained functional at all time points (12). However, mice i.n. immunized with bone marrowderived DCs did not exhibit lung T CD8 impairment. Additionally, mice infected with HMPV and subsequently challenged with either HMPV or peptide-loaded bone marrow-derived DCs exhibited the same degree of impairment in both groups of mice, indicating that additional DCs could not rescue the phenotype. Genetic ablation or Ab blockade of PD-1 in vivo and in vitro (which did not affect APC numbers) restored T CD8 functionality in the ICS assay (12, 13). Taken together, these data support a cellintrinsic role for PD-1 in lung T CD8 impairment.
We then profiled global gene expression in impaired lung versus unimpaired spleen epitope-specific T CD8 to identify pathways that might explain the stark difference in functionality observed between these two populations. Lung T CD8 exhibited a more diverse pattern of gene expression, suggesting that exposure to viral Ag in the infected milieu drives further differentiation, which was confirmed by subsequent experiments showing the upregulation of inhibitory receptors in response to cognate Ag-induced TCR signaling. Lung T CD8 exhibited a more diverse pattern of gene expression than did spleen T CD8 , expressing an additional 319 genes. They upregulated expression of numerous genes encoding chemokines, including CCL1, CCL3, CCL4, CXCL9, and CXCL15, suggesting a role for lung T CD8 in recruiting other inflammatory cells to the infected lung. They transcribed more Ifng, Tnfa, and Il2 mRNA despite a decreased ability to produce these cytokines, suggesting posttranscriptional regulation of gene expression, which has been observed during exhaustion (4).
Recently the transcriptional circuitry that regulates effector, memory, and exhausted T CD8 has been defined (reviewed by Kaech and Cui in Ref. 1). T-bet, which supports effector T CD8 function and prevents exhaustion (53), and Eomes, which promotes exhaustion + (left), functional epitope-specific T CD8 (middle), and the total number of tetramer + T CD8 (right) were calculated. For each bar, the epitope analyzed is given with the treatment directly below. A34R + and M195 + T CD8 responses in mock-treated mice are from the same infected animals. Results are combined from three independent experiments with five mice per group. *p , 0.05, ***p , 0.001, unpaired t test.
(54), were not differentially expressed between spleen and lung T CD8 in our study. Fos and Jun, two proteins that form the heterodimeric transcription factor AP-1, were both more highly expressed in lung T CD8 . AP-1 was recently described as a transcriptional activator of PD-1 (55) and so may represent a link between Ag-induced TCR signaling and PD-1. The genes encoding transcription factors Id2 and Id3 were more highly expressed in lung T CD8 . ID2 supports development of terminal effectors (56) whereas ID3 promotes survival of long-lived memory cells (57). ID2 could contribute during early effector differentiation of lung T CD8 , but the contribution of each of these transcriptional regulators to impairment remains to be defined. Additionally, the Prdm1 gene, which encodes the transcriptional repressor BLIMP-1, was upregulated in lung T CD8 , whereas BCL-6, which opposes BLIMP-1 activity, was downregulated in both lung and spleen T CD8. During acute infections, high BLIMP-1 expression enhances T cell functions and the formation of KLRG1 high IL-7R low terminal effectors (58). During chronic infection, BLIMP-1 is highly expressed in association with the upregulation of inhibitory receptors (40).
During viral LRI, a role for BLIMP-1 has been described in the generation of IL-10-producing effector T CD8 (60). Given the high expression of inhibitory receptors on lung T CD8 , BLIMP-1 in these cells may promote functional impairment, but further experiments are necessary to explore this possibility.
Lung T CD8 expression of T-bet, BLIMP-1, AP-1, and ID2 during acute viral LRI all imply an effector phenotype. Indeed, lung T CD8 are effectors that produce cytokines, degranulate, and kill infected cells. However, they rapidly lose these effector functions in conjunction with coordinated upregulation of several inhibitory receptors. These inhibitory receptors temper immune responses in a number of settings (54), and their roles in LRI are not well understood. TIM-3, which is coexpressed by PD-1 + T cells during chronic infections (25) and cancer (61), also impairs T cell responses during acute viral infections (62, 63). 2B4 can be either inhibitory or stimulatory (64), but in the setting of chronic infection it contributes to the rapid impairment of memory T CD8 (27). Lung T CD8 also expressed higher levels of Il10 and Il10ra mRNA. T cells are the primary producers of IL-10 during LRI (65), and it has been proposed that their expression of IL-10R facilitates an intrinsic T CD8 counterregulatory mechanism (60), suggesting that IL-10 may also be a key mediator of T CD8 impairment. However, unlike during chronic infection where IL-10 blockade enables clearance of an established infection (66), blocking IL-10 during acute infection only serves to increase inflammation and not accelerate viral clearance (60), so its application in therapeutic approaches may be limited.
Interestingly, we observed a significant overlap in the gene expression profile of impaired lung T CD8 during acute viral LRI and exhausted T CD8 during chronic viral infection. This was especially true when examining genes with known immune functions. Notably, impaired lung T CD8 resemble exhausted cells more than they do functional splenic cells or even effector splenic T CD8 during acute LCMV infection. It is unlikely that lung T CD8 exist in other states of unresponsiveness, such as anergy or senescence, as genes associated with these conditions were not upregulated. Previous reports have also described exhaustion as unique from these states (4).
The functional impairment, upregulation of similar inhibitory receptors, and overlapping gene expression profiles shared by lung T CD8 during acute viral LRI and T CD8 during chronic LCMV infection suggest a similar functional state. This has been described as exhaustion, which is secondary to repetitive TCR stimulation during chronic infection and cancer. However, this paradigm may need revising given our results that exhaustion can develop rapidly in the right setting, namely, acute viral infection of an organ with critical importance with regard to survival. A similar functional state of anti-viral T CD8 may exist in acute CNS infections, such as that seen during rabies (18) and coronavirus (47) infection. A key similarity in all these settings is the exposure of T CD8 to viral Ag during infection. However, the degree to which viral Ag alone mediates exhaustion is unclear. It is likely that varying levels of Ag are expressed at different times and in different organs during these acute infections and also during chronic infections. A key future direction will be to explore the factors present in each organ during infection that mediate exhaustion. Understanding these process will allow for more targeted therapies, especially now that PD-1 blockade is being used clinically for cancer treatment. The effects of these treatments may vary widely based on the local environment in the target tissue with differing levels of Ag, inhibitory receptors, immunomodulatory ligands, and cytokines.
Whereas the gene expression profile of lung T CD8 shares many similarities with exhausted T CD8 , it also preserves a core signature of unique genes. For example, lung T CD8 more highly express the transcription factors ID3, IRF8, and AP-1 than do early effector, early exhausted, or late exhausted T CD8 . Some of the unique transcripts may represent networks of genes required to exist in the lung environment, and many of them are immune genes with well-characterized functions. It will be interesting to decipher the role of these and other gene products in enforcing T CD8 impairment versus allowing for control of respiratory virus infections.
In summary, we have shown that PD-1 cell-intrinsically regulates lung T CD8 impairment and that lung T CD8 rapidly acquire a gene expression profile resembling the exhausted state observed during chronic infection. Their differentiation state comprises elements of both effector and exhausted T cells that may allow them to balance control of pathogen spread with prevention of immunemediated tissue damage. We confirmed coexpression of PD-1, TIM-3, LAG-3, and 2B4 by lung T CD8 with a relative lack of these receptors by functional spleen T CD8 . Our results indicate that acute viral LRI induces an exhaustion-like state in lung T CD8 characterized by rapid functional impairment and Ag-dependent upregulation of numerous inhibitory receptors. Further exploration of the roles of these inhibitory receptors in T cell impairment may yield novel targets for therapeutics or vaccine strategies against respiratory virus infections.
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Supplemental Table 1 . Genes differentially expressed comparing spleen, lung primary, and lung secondary CD8 to naive CD8. 
